Fred Gebhart, Drug Topics contributing editor, lays out the history of compounding and introduces three experts in the pharmaceutical compounding field.
Fred Gebhart, Drug Topics contributing editor, lays out the history of compounding and introduces three experts in the pharmaceutical compounding field: Lawrence Maida, proprietor, pharmacist in charge, Maida Pharmacy and Compounding Center; Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates; and Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.